Icon
+91 94997 68112
Login Register

ADRENALIN - (1mg Base/ml; Solution, Intramuscular, Intravenous,)

EPINEPHRINE Par Pharma
1mg Base/ml; Solution, Intramuscular, Intravenous,
Less Than $1000 mn
Less Than 5
Less Than 5
More Than 5
 None
Less Than 5
Less Than 5
Emergency treatment in anaphylaxis. Bronchospasm. Urticaria. Angioedema. Serum sickness.
Yes
******** ** *** ***** ** **** **** ** **** ******* '***, '*** (**** ******** ** ***** **, ****) *** *** ************ *********. ** ****** **** **** ******** ****** ** *** ****. *** ******* ***** *** *** *********** ***** ** *** **********. *****, ********** ********* **** ******** *** **** ***** ******** *** *** ********* *** ** *** *** ********** (****** ********, *******, **************, ** **********, ** ***** *** ******** ** ***********) *** ***** *** *********** ***** ** ******* ******* *** ****** *** ********** *** ********* **** ********.. ******* **** ***** * **** ** ** **** '*** *** '*** ******* *** *** *********. ******* **** *** **** ******* **** ****** ** **** ******* *** ***** ***** **** ******* ***'* ****** ******* ********* ***** ********** ** '*** ******(*.* ***** ***** **, ****)
ADRENALIN Patent 1 Patent 2
******** ******* ***** *** ** ** ******* ***** *** ** **
******* *** **** ** ** **** ** **
**** ****** **** ** *** **, **** **** ** *** **, ****
Company FTF Status / 180 days exclusivity 30-Months stay Current Litigation Status Current Approval Status Likelihood of launch
******** *** \ *** *** **, **** **** ******* ***** ******** *** ** ** ******** ******** ** *** ****
******* *** ** \ ** *** **, **** ******* **** ** ** **** ***** ***** **, ****
**** ****** ** \ ** *** **, **** ******* **** ******* *** **** *** *** ****
  1. *** *, **** : ******** ******** *** ******* ***** *** **** ** **** ******* '***, '*** (**** ******** ** ***** **, ****).
  2. *** **, **** : *** ******* ***** * **** ******* ******** ** ******** ***** ** ** *** ******** ***** ** ******* ******** ** *******.
  3. *** *, **** : ***** ***** ******** *** *** ********* *** ** *** *** ********** (****** ********, *******, **************, ** **********, ** ***** *** ******** ** ***********) *** ***** *** *********** ***** ** ******* ******* *** ****** *** ********** ********* **** ********.
  4. *** *, **** : ******* ******** *** ******* ***** **'* **** ** ****** **** ******* '***, '*** (**** ******** ** ***** **, ****).
  5. *** **, **** : *** ******* ***** * **** ******* ******* **** ******* '***, '*** (**** ******** ** ***** **, ****).
  6. *** *, **** : ******** *** ********. *****://***.**********.***.***/**********_****/*********/****/******************.***
  7. *** **, **** : ***** ***** **** '*** *** '*** ******* *** ********* ** *******. ******* ***'* ****** **** ******* ***** ********** ** '*** ****** (*.* ***** ***** **, ****)
  8. :
  9. *** **, **** : **** ******** ******** *** ******* ***** *** **** ** ******.
  10. *** **, **** : *** **** **** ******* *** ************ ** ****** '***, '***.
  11. *** **, **** : *** *********** ******* **** ****** ******* ********* ** **** ******** *** *** *** ****** ** ****** ** *********** ****** ** **** ******. *** **** *** **** ****** ****.

ADRENALIN - (30mg/30ml; injection)

EPINEPHRINE Par Pharma
30mg/30ml; injection
Less Than $1000 mn
Less Than 5
Less Than 5
More Than 5
 None
Less Than 5
Less Than 5
Emergency treatment in Anaphylaxis, bronchospasm, urticaria, angiodema, serum sickness
Yes
************* ********** ******* ** ***. ** ***** * **** ** **** ******* '***, '***, '***, *** *** *** *********. *****, ************* ********** ******* *** *** ******** *** ******** ******* ** *** **** **** *** **** ***********.
ADRENALIN Patent 1 Patent 2 Patent 3
************* ********** ******* *** *** ********* *** ********* *** *********
Company FTF Status / 180 days exclusivity 30-Months stay Current Litigation Status Current Approval Status Likelihood of launch
************* ********** ******* *** *** \ *** ** *** ********* ******** ******** ** *** **, ****
  1. *** **, **** : ************* ********** *******, ***. (***) ***** * **** ** **** ******* '***, '***, '***
  2. *** **, **** : *** (*********) ******** ***** ********
  3. *** **, **** : *** (*********) ******** *** *******

Download ParaIV Report

Download ParaIV Detailed Report

To get detailed report Contact Us

ParaIV Advanced Search






Please contact contact@researchdelta.com to get more details.

Headquarters

Research Delta Advisor, G4,Sani Apartment, Bank of india lane, Ellora park, Vadodara 390023

+91 94997 68112

nimish@researchdelta.com

Products & Services

Para IV GenUS Pharmalysis Consulting Valuation

Quick Links

Home About Career Media Coverage Contact
© Research Delta, All Right Reserved.